Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: axial who wrote (13521)	6/14/2004 4:26:01 PM
From: Cal Gary	Read Replies (1) \| Respond to of 14101

I believe this is the first time I have reviewed OXO's financial statement. sedarfiles.stockwatch.com DMX paid ~~$50mm usd for a near bankrupt company. Why? To save it from a creditor? To save its investment? Patent rights that have been written down to $2. Liabilities "The balance sheet of OXO Chemie AG shows at the end of December, accumulated losses of US$34,306,105 and the company is in a situation of bankruptcy for a net amount of US$14,843,672. In order to permit the Board of Directors not to notify the judge in accordance with Article 725 paragraph 2 of the Swiss Code of Obligations, it was decided to subordinate all Shareholder’s debts amounting to US$14,345,799. However, the net equity is still negative for an amount of US$497,873, following this subordination." Subordinate shareholder's loan = $15,058,192 Subordinated Shareholder’s loan (note 4) 4. Subordinated Shareholder’s loan The shareholder’s loan payable to Dimethaid Research Inc. bears interest at the Canadian prime rate established by the Canadian Imperial Bank of Commerce plus 1%. The shareholder has agreed to subordinate all its existing and future claims against the Company until such time as the Company has been restored to a positive equity position.